COGNITIVE ENHANCEMENT COGNITIVE ENHANCEMENT: methods, ethics, regulatory challenges COGNITIVE ENHANCEMENT as a treatment for drug addictions Neuroethical issues in COGNITIVE ENHANCEMENT Non-pharmacological COGNITIVE ENHANCEMENT COGNITIVE […]

BRAIN metabolism during FASTING Caloric restriction and intermittent FASTING: two potential diets for successful BRAIN aging FASTING is neuroprotective following traumatic BRAIN injury The Effects of […]

PROTEIN CARBONYLATION PROTEIN CARBONYLATION in human diseases PROTEIN CARBONYLATION, cellular dysfunction, and disease progression Cell signaling by PROTEIN CARBONYLATION and deCARBONYLATION PROTEIN CARBONYLATION as a major […]

ANTI‐GLYCATIVE and ANTI‐inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice ANTI-oxidative, ANTI–GLYCATIVE and ANTI-apoptotic effects of oleanolic acid in brain of […]

EXTRACELLULAR GLYCATION crosslinks: prospects for removal Attenuation of EXTRACELLULAR MATRIX accumulation in diabetic nephropathy by the advanced GLYCATION end product cross-link BREAKER ALT-711 via a protein […]

GLYCATION and diabetic complications Role of GLYCATION in aging Mechanisms of GLYCATION in atherogenesis The pathological implications of protein GLYCATION. GLYCATION products and the pathogenesis of […]

The HPA axis is involved in the neurobiology of mood disorders and functional illnesses, including anxiety disorder, bipolar disorder, insomnia, posttraumatic stress disorder, borderline personality disorder, […]

Free γ –AMINOBUTYRIC ACID in brain The action of γ –AMINOBUTYRIC ACID on cortical neurones γ –AMINOBUTYRIC ACID in brain: its formation from glutamic ACID Biochemical-physiology […]

DYNORPHIN 1–8 and DYNORPHIN 1–9 are ligands for the κ-subtype of opiate receptor Behavioral effects and in vivo degradation of intraventricularly administered DYNORPHIN-(1-13) and D-Ala2-DYNORPHIN-(1-11) in […]